Table 1.
Late toxicity assessed using Radiation Therapy Oncology Group (RTOG), Royal Marsden Hospital (RMH) and Late Effects on Normal Tissues: Subjective: Objective/Management (LENT/SOM) scoring systems: bowel toxicity (in rectum volume matched dataset) and bladder toxicity (in bladder volume matched dataset)
Grade | Rectum volume matched dataset |
Bladder volume matched dataset |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RTOG bowel |
RMH bowel |
LENT/SOM bowel |
RTOG bladder |
RMH bladder |
LENT/SOM bladder |
||||||||
FP |
IP |
FP |
IP |
FP |
IP |
FP |
IP |
FP |
IP |
FP |
IP |
||
n = 53 |
n = 53 |
n = 53 |
n = 53 |
n = 53 |
n = 53 |
n = 61 |
n = 61 |
n = 61 |
n = 61 |
n = 61 |
n = 61 |
||
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
6 months | 0 | 44 (90) | 46 (87) | 43 (88) | 47 (90) | 38 (78) | 43 (81) | 59 (98) | 57 (93) | 40 (67) | 40 (66) | 43 (72) | 31 (51) |
1 | 3 (6) | 7 (13) | 4 (8) | 5 (10) | 9 (18) | 7 (13) | 0 | 4 (7) | 16 (27) | 19 (31) | 10 (17) | 21 (34) | |
2 | 2 (4) | 0 | 2 (4) | 0 | 1 (2) | 2 (4) | 1 (2) | 0 | 3 (5) | 2 (3) | 6 (10) | 8 (13) | |
3 | 0 | 0 | 0 | 0 | 1 (2) | 1 (2) | 0 | 0 | 1 (2) | 0 | 1 (2) | 1 (2) | |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Not assessed | 4 | 0 | 4 | 1 | 4 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | |
Mann–Whitney P value | 0.701 | 0.628 | 0.699 | 0.188 | 0.985 | 0.036 | |||||||
12 months | 0 | 44 (88) | 45 (85) | 35 (70) | 46 (87) | 33 (67) | 40 (76) | 56 (97) | 58 (95) | 36 (62) | 41 (67) | 42 (72) | 29 (48) |
1 | 4 (8) | 7 (13) | 13 (26) | 6 (9) | 13 (27) | 11 (21) | 1 (2) | 2 (3) | 18 (31) | 17 (28) | 10 (17) | 25 (41) | |
2 | 2 (4) | 1 (2) | 1 (2) | 1 (2) | 2 (4) | 2 (4) | 1 (2) | 1 (2) | 1 (2) | 2 (3) | 4 (7) | 6 (10) | |
3 | 0 | 0 | 1 (2) | 1 (2) | 1 (2) | 0 | 0 | 0 | 3 (5) | 1 (2) | 2 (4) | 1 (2) | |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Not assessed | 3 | 0 | 3 | 0 | 4 | 0 | 3 | 0 | 3 | 0 | 3 | 0 | |
Mann–Whitney P value | 0.690 | 0.047 | 0.350 | 0.697 | 0.524 | 0.016 | |||||||
18 months | 0 | 39 (81) | 49 (94) | 35 (73) | 46 (89) | 32 (67) | 46 (89) | 50 (93) | 56 (93) | 34 (62) | 38 (63) | 38 (72) | 35 (59) |
1 | 7 (15) | 2 (4) | 11 (23) | 5 (10) | 10 (21) | 4 (8) | 3 (6) | 3 (5) | 19 (35) | 20 (33) | 4 (8) | 18 (31) | |
2 | 2 (4) | 1 (2) | 1 (2) | 1 (2) | 4 (8) | 2 (4) | 1 (2) | 0 | 1 (2) | 1 (2) | 9 (17) | 5 (9) | |
3 | 0 | 0 | 1 (2) | 0 | 2 (4) | 0 | 0 | 1 (2) | 1 (2) | 0 | 2 (4) | 0 | |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 (2) | 0 | 1 (2) | |
Not assessed | 5 | 1 | 5 | 1 | 5 | 1 | 7 | 1 | 6 | 1 | 8 | 2 | |
Mann–Whitney P value | 0.049 | 0.050 | 0.008 | 0.883 | 0.866 | 0.460 | |||||||
24 months | 0 | 44 (90) | 48 (96) | 33 (67) | 44 (88) | 32 (65) | 42 (86) | 51 (94) | 56 (98) | 37 (69) | 39 (68) | 34 (63) | 34 (60) |
1 | 5 (10) | 1 (2) | 15 (31) | 5 (10) | 14 (19) | 6 (12) | 3 (6) | 0 | 14 (26) | 14 (25) | 10 (19) | 17 (30) | |
2 | 0 | 1 (2) | 1 (2) | 1 (2) | 2 (4) | 1 (2) | 0 | 1 (2) | 2 (4) | 3 (5) | 9 (17) | 4 (7) | |
3 | 0 | 0 | 0 | 0 | 1 (2) | 0 | 0 | 0 | 1 (2) | 1 (2) | 1 (2) | 2 (4) | |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Not assessed | 4 | 3 | 4 | 3 | 4 | 4 | 7 | 4 | 5 | 4 | 7 | 4 | |
Mann–Whitney P value | 0.247 | 0.016 | 0.019 | 0.298 | 0.954 | 0.984 |
FP, forward planned; IP, inverse planned.